AM
AnGes, Inc.
AMGXF · OTC
$0.36 +0.00% (+$0.00)
Market Cap ¥22.4B
P/E Ratio -
Div. Yield -
ROE 162.36%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 109.83x
P/S 23.25x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 53.40%
Rev. growth 135.41%
FCF growth N/A
Profitability
18 /100
Weak Net margin 401.99%
Op. margin 621.56%
FCF margin 0.00%
Quality
3 /100
Poor ROE 162.36%
ROA 106.71%
Asset turnover 0.27x
Debt
8 /100
High Current ratio 0.95x
Int. coverage -388.66x
Debt/Equity 3.52x
Stability
26 /100
Unstable Rev. volatility 145.32%
EPS volatility 171.29%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AMGXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ei Yamada
Employees
56
Headquarters
Ibaraki
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report